Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis

BACKGROUND: During COVID-19 pandemic, the safety of medical therapies for inflammatory bowel disease (IBD) in relation to COVID-19 has emerged as an area of concern. This study aimed to evaluate the association between IBD therapies and severe COVID-19 outcomes. METHOD: We performed a systematic rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Alrashed, Fatema, Battat, Robert, Abdullah, Israa, Charabaty, Aline, Shehab, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561831/
https://www.ncbi.nlm.nih.gov/pubmed/34725056
http://dx.doi.org/10.1136/bmjgast-2021-000774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561831/
https://www.ncbi.nlm.nih.gov/pubmed/34725056
http://dx.doi.org/10.1136/bmjgast-2021-000774

Ejemplares similares